Targeted therapies in melanoma.

Abstract excerpt

Advances in the biology of melanoma have provided insights about chemoresistance and its genetic heterogeneity in parallel with advances in drug design, culminating in recent major treatment breakthroughs. Although clinical benefit of targeted therapies has been unquestionable, future advances are only possible if we understand the interplay between genetic aberrations and role of other crucial nongenetic changes...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Melanoma
• Share to Molecular Targeted Therapy
• Share to Mutation